or Try an Advanced Search...

    ETF Components for BIGT - L&G Pharma Breakthrough UCITS ETF


    Below is a list of stocks held by this ETF. We only list holdings in the same market. If this is a global ETF, there may be additional components other than those listed here.

    Holdings

    Symbol Grade Price % Change Allocation
    0MH6 A -0.44 2.64
    0RQE F -8.10 2.44
    0DPB F 0.00 2.38
    0QLR B 0.81 2.33
    0QZU C -0.24 2.33
    0L35 B 9.40 2.32
    0R1B D 1.11 2.21
    0RC6 F 0.00 2.19

    Represented by ETF Holdings

    Keywords: Biopharmaceutical Drugs Medical Specialties Organ Systems Rare Diseases Alzheimer's Disease Duchenne Muscular Dystrophy Follicular Lymphoma Gene Therapy Immunosuppressants Medicine Monoclonal Antibodies Multiple Sclerosis Muscular Dystrophy Neuroscience Orphan Drugs Plaque Psoriasis Smallpox Vaccination Vaccines
    Industries: Drug Manufacturers - Major

    Recent News for L&G Pharma Breakthrough UCITS ETF & its Holdings

    Date Stock Title
    The objective of the fund is to provide exposure to a basket of stocks of companies that are actively engaged in the research, development and/or manufacturing of orphan drugs. The Index selects stocks that meet certain size and liquidity requirements using a two-fold approach that is primarily based on the trend in the valuation of a company’s orphan drug portfolio and its overall revenue forecasts.
    Manufacturing Revenue Valuation Drugs Foreign Exchange Market Fundamental Analysis Fold Market Liquidity
    Back to the Main BIGT Page...